Schumacher, M., Schmidt, D., Jurklies, B., Gall, C., Wanke, I., Schmoor, C., Maier-Lenz, H., Solymosi, L., Brueckmann, H., Neubauer, A.S., Wolf, A., and Feltgen, N. (2010) Central Retinal Artery Occlusion: Local Intra-Arterial Fibrinolysis versus Conservative Treatment, a Multicenter Randomized Trial. Ophthalmology, 117, 1367-1375.
https://doi.org/10.1016/j.ophtha.2010.03.061

has been cited by the following article:

• TITLE: Localized Administration of Tissue Plasminogen Activator through the Ophthalmic Artery in the Setting of Central Retinal Artery Occlusion

  AUTHORS: Deanna Ingrassia Miano, Gilbert Xue, Erika White, Faisal Ridha Al-Timimi

  KEYWORDS: Central Retinal Artery Occlusion, Ophthalmology, Neuroendovascular, Localized Intra-Arterial Fibrinolysis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.11 No.5, May 17, 2022

  ABSTRACT: Treatment of central retinal artery occlusion (CRAO) has been an ambiguous entity in the medical community. Many interventions have been explored; however, a standard of care has yet to be defined. Recent studies have suggested localized intra-arterial fibrinolysis as a promising method; however, a timeframe for optimal treatment initiation continues to be investigated. This case demonstrates an instance of CRAO treated with local fibrinolysis, however, what could be due to delayed time-to-treat, final visual outcomes were unfavorable. In conjunction with supporting literature, we believe optimization of thrombolytic protocols should be sought after to facilitate successful treatment outcomes. In addition, we encourage community awareness of the signs and symptoms of CRAO in hopes that earlier patient presentations will lead to swifter interventions and overall preservation of ocular function.